Diabetes Mellitus Flashcards

1
Q

What’s DM?

A

DM is a group of metabolic diseases characterized by hyperglycemia resulting from impaired secretion of insulin, impaired action of insulin or both

The chronic hyperglycemics of diabetes is associated with long-term damage,dysfunction failure of various organs, eye, kidney, heart, blood vessels, nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physiology of DM and action of insulin

A

Betacells from pancreas secrete insulin,

Insulin acts on target tissues (e.g., muscle, liver, and adipose tissue

Insulin connect/ bind with specific receptors( insulin receptors) on cell surface to transport glucose to or in the cell.

Insulin Regulates/ maintains the normal glucose levels (3.3-5-5
M/mol/L)

Insulin also takes part in protein synthesis and lipid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Levels that regulate glucose

A

For insulin
Glycogen synthesis+
Gluconogenesis-
Glycolysis+

For Glucagon/ glucocorticoids
Glycogen synthesis-
Gluconogenesis+
Glycolysis-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

More info on the levels that regulate glucose

A

Glycogen Synthesis (Glycogenesis)
Glycogen synthesis, also known as glycogenesis, is the process by which glucose molecules are converted into glycogen, a storage form of glucose in the body. Glycogenesis primarily takes place in the liver and muscle cells. It is stimulated by insulin and facilitated by the enzymes glycogen synthase and branching enzyme. Glycogen is an important energy reserve that can be broken down into glucose during periods of fasting or increased energy demand, such as during exercise.
Gluconeogenesis
Gluconeogenesis is the process of generating glucose from non-carbohydrate sources, such as lactic acid, glycerol, and certain amino acids. This process occurs primarily in the liver and, to a lesser extent, in the kidneys. Gluconeogenesis is essential during periods of fasting, intense exercise, or low carbohydrate diets, as it helps to maintain a stable blood glucose level and provide energy to glucose-dependent tissues like the brain and red blood cells. Key enzymes involved in gluconeogenesis include pyruvate carboxylase, phosphoenolpyruvate carboxykinase, fructose 1,6-bisphosphatase, and glucose 6-phosphatase.
Glycolysis
Glycolysis is a metabolic pathway that breaks down glucose (a six-carbon molecule) into two molecules of pyruvate (a three-carbon molecule). This process occurs in the cytoplasm of cells and generates ATP (adenosine triphosphate), NADH (nicotinamide adenine dinucleotide), and other intermediate metabolites. Glycolysis is an anaerobic process (does not require oxygen) and serves as a primary energy source for cells, especially under anaerobic conditions or during periods of high energy demand. Key enzymes involved in glycolysis include hexokinase, phosphofructokinase-1, and pyruvate kinase.
In summary, glycogenesis and gluconeogenesis are two opposing metabolic pathways responsible for the synthesis and degradation of glycogen, respectively. Glycogen acts as an energy storage molecule. Glycolysis, on the other hand, is the breakdown of glucose to produce energy in the form of ATP, which fuels various cellular processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

More info on the levels that regulate glucose

A

Glycogen Synthesis (Glycogenesis)
Glycogen synthesis, also known as glycogenesis, is the process by which glucose molecules are converted into glycogen, a storage form of glucose in the body. Glycogenesis primarily takes place in the liver and muscle cells. It is stimulated by insulin and facilitated by the enzymes glycogen synthase and branching enzyme. Glycogen is an important energy reserve that can be broken down into glucose during periods of fasting or increased energy demand, such as during exercise.
Gluconeogenesis
Gluconeogenesis is the process of generating glucose from non-carbohydrate sources, such as lactic acid, glycerol, and certain amino acids. This process occurs primarily in the liver and, to a lesser extent, in the kidneys. Gluconeogenesis is essential during periods of fasting, intense exercise, or low carbohydrate diets, as it helps to maintain a stable blood glucose level and provide energy to glucose-dependent tissues like the brain and red blood cells. Key enzymes involved in gluconeogenesis include pyruvate carboxylase, phosphoenolpyruvate carboxykinase, fructose 1,6-bisphosphatase, and glucose 6-phosphatase.
Glycolysis
Glycolysis is a metabolic pathway that breaks down glucose (a six-carbon molecule) into two molecules of pyruvate (a three-carbon molecule). This process occurs in the cytoplasm of cells and generates ATP (adenosine triphosphate), NADH (nicotinamide adenine dinucleotide), and other intermediate metabolites. Glycolysis is an anaerobic process (does not require oxygen) and serves as a primary energy source for cells, especially under anaerobic conditions or during periods of high energy demand. Key enzymes involved in glycolysis include hexokinase, phosphofructokinase-1, and pyruvate kinase.
In summary, glycogenesis and gluconeogenesis are two opposing metabolic pathways responsible for the synthesis and degradation of glycogen, respectively. Glycogen acts as an energy storage molecule. Glycolysis, on the other hand, is the breakdown of glucose to produce energy in the form of ATP, which fuels various cellular processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Classifications of DM

A

Type I - idiopathic and autoimmune( immune mediated)

Type 2 - insulin resistance and insulin secretory deficiency

Others specify-

a)Monogenic DM(MODY)- typical for young people basically like type one with mild symptoms of type 2 caused by mutation of genes responsible for insulin secretion. usually develops before the age of 25

b)Secondary DM- i) by endocrine disorders normally with hyper production of hormones example Pheochromocytoma(that produces an excessive amount of adrenaline and noradrenaline). Cushing’s Syndrome ( caused by the overproduction of cortisol, a stress hormone produced by the adrenal gland)

ii) by pancreas disease- Pancreatic Trauma (Traumatic injuries to the pancreas), chronic pancreatitis,cystic fibrosis,

c)Drug induced DM- glucocorticoids drugs

Gestation Diabetes-leaves after pregnancy
Diabetes in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type one DM

A

Type 1 Diabetes
Type 1 diabetes, also known as insulin-dependent, is an autoimmune disorder where the body’s immune system attacks and destroys insulin-producing beta cells in the pancreas.
It usually develops in childhood or adolescence but can occur at any age.

Fast process, severe leads to absolute insulin
Insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type one symptoms

A

Thirst, weight loss, hunger, polyuria,
Excessive thirst and increased fluid intake (polydipsia).
Frequent urination (polyuria), particularly at night (nocturia).
Unexplained weight loss, despite increased appetite and food intake (polyphagia).
Fatigue and weakness due to the body’s inability to properly use glucose for energy.
Blurred vision as a result of high blood glucose levels causing fluid shifts in the eye.
Slow-healing wounds and frequent infections, as high blood glucose can impair the immune system and hinder wound healing.
Nausea, vomiting, or stomach pain, which can occur as a result of diabetic ketoacidosis (DKA), a life-threatening complication of Type 1 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type two DM

A

Type 2 diabetes, also known as non-insulin-dependent or adult-onset diabetes, is the most common form of diabetes.
It occurs when the body becomes resistant to the effects of insulin or does not produce enough insulin to meet its needs.
Type 2 diabetes typically develops in adulthood, but is increasingly seen in children and adolescents due to rising obesity rates.
Gradual, mild clinical symptoms, problem with receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Symptoms of type two

A

Obesity,
Increased thirst and frequent urination: Just like in Type 1 diabetes, the body tries to rid itself of excess glucose through urine, leading to increased thirst and urination.
Fatigue: High blood glucose levels can cause fatigue, as the body is unable to use glucose for energy effectively.
Blurred vision: High blood glucose levels can cause fluid shifts in the eye, leading to blurred vision.
Slow healing wounds: High blood glucose levels can impair the immune system and delay wound healing.
Numbness or tingling in the hands or feet: Over time, high blood glucose levels can cause nerve damage, resulting in numbness or tingling sensations in the extremities.
Dark patches of skin: Diabetes can cause dark patches of skin, especially in the armpits and neck.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DM diagnostics

A

Blood glucose test( capillary/ venous)
Oral glucose tolerance
Glycated hemoglobin BT( HBAIc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DM Insulin therapy- absolute indication for insulin

A

DM type 1
DM + diabetes ketoacidosis , diabetic coma
DM+ pregnancy
DM type2 + therapeutic failure of oral antidiabetic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Normal secretion of Insulin in thebody

A

A) basal secretion- insulin is secreted in Bits (long and intermediate)
B) prandial secretion -meal secretion here insulin increases after eating ( short acting and rapid)
Mixed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prandial secretion rapid acting drugs and short acting drugs

A

Prandial secretion refers to the release of certain hormones or enzymes in response to food intake.

Rapid-acting insulin: These drugs are designed to be absorbed quickly and start working within 15 minutes, with a peak action time of about 1 hour

Rapid-acting insulin:
NovoLog (insulin aspart)
Humalog (insulin lispro)
Apidra (insulin glulisine)

Short-acting insulin: These drugs take longer to start working compared in to rapid-acting insulin, usually beginning to act within 30 minutes and peaking after 2-3 hours

Short-acting insulin:
Regular insulin (Humulin R)
Actrapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

basal secretion interme acting drugs and long acting drugs Examples

A

Basal secretion refers to the continuous release of insulin by the pancreas to meet the body’s needs between meals and during periods of fasting

Intermediate-acting insulin:
Humulin N (NPH insulin)
Novolin N (NPH insulin)

Long-acting insulin:
Lantus (insulin glargine)
Levemir (insulin detemir)
Tresiba (insulin degludec)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DM insulin therapy
Insulin regimen

A

Intensive insulin Therapy
Conventional insulin therapy

17
Q

Difference between intensive and conventional insulin therapy

A

A.Intensive insulin therapy involves multiple daily injections or or the use of an insulin pump to deliver insulin throughout the day while conventional therapy usually requires one or two injections per day

B. Due to its focus on tight glycemic control, intensive insulin therapy may increase the risk of hypoglycemic events compared to conventional therapy.

C. Intensive therapy has been shown to reduce the risk of long-term diabetes-related complications, such as retinopathy, nephropathy, and neuropathy, compared to conventional therapy

C.

18
Q

Intensive insulin therapy and conventional insulin therapy

A

Intensive involves combination of basal insulin (long-acting) and bolus/prandial insulin (rapid-acting)
Usually for type 1DM
One drug is normally used

conventional involves use of insulin twice. before breakfast and dinner
Type 2DM
Simpler

19
Q

DM
Insulin therapy
Devices for injection
And technique

A

Insulin syringe- subcutaneously 90
Pen-injector
Insulin pump
Injection Aids
Insulin Inhalers

Area
Arms (triceps)
Abdomen (umbilical region)
Upper outer quadrant of Glutes
Upper anterior lateral of area of hip

20
Q

Indication for oral anti diabetic drugs treatment
And
Contraindications

A

Indications
DM type 2
Prediabetes ( metformin

Contraindications
Diabetic ketacidosis
Diabetic coma
Renal, hepatic failure

21
Q

The pathophysiology of type 2 diabetes mellitus (T2DM) involves a complex interplay of genetic, environmental, and lifestyle factors that contribute to the development of insulin resistance and impaired insulin secretion.

A

Insulin Resistance: Insulin resistance is a decreased ability of target tissues (such as muscle, fat, and liver) to respond to insulin, leading to reduced glucose uptake and utilization. This is one of the earliest detectable abnormalities in T2DM.
Beta Cell Dysfunction: Pancreatic beta cells, responsible for insulin production, initially compensate for insulin resistance by increasing insulin secretion. However, over time, beta cell function declines, leading to insufficient insulin production to overcome insulin resistance.
Increased Glucagon Secretion: In T2DM, there is often increased secretion of glucagon, a hormone that stimulates glucose release from the liver. This contributes to elevated blood glucose levels.
Impaired Incretin Effect: Incretins are gut hormones that stimulate insulin secretion in response to meals. In T2DM, the incretin effect is reduced, leading to decreased insulin secretion and increased postprandial glucose levels.
Altered Fat Metabolism: Insulin resistance affects fat metabolism, leading to increased lipolysis and elevated levels of free fatty acids in the blood. This can cause ectopic fat deposition in the liver and muscle, contributing to insulin resistance.
Inflammation: Chronic low-grade inflammation is observed in T2DM, which may contribute to insulin resistance and beta cell dysfunction. Adipose tissue inflammation and activation of immune cells play a role in this process.
Genetic Factors: Genetic susceptibility plays a role in the development of T2DM, with multiple genes identified as contributing factors. These genes influence various aspects of insulin action, secretion, and metabolism.
Lifestyle Factors: Sedentary lifestyle, unhealthy diet, and obesity are significant risk factors for developing T2DM. They exacerbate insulin resistance and beta cell dysfunction, leading to disease progression.
The pathophysiology of type 2 diabetes involves a combination of these factors, leading to hyperglycemia, dyslipidemia, and increased risk of cardiovascular complications. Treatment strategies for T2DM aim to address these underlying abnormalities, focusing on lifestyle modifications, improving insulin sensitivity, and enhancing insulin secretion.

22
Q

Oralantidiabeticdrugs

A

Oral forms and subcutaneous forms

23
Q

Oral forms

A

A. Drugs that reduce insulin resistance-biguanides(metformin)

B. Drugs the enhance insulin secretion-sulfonylurea(Glimepiride,Glibenclamide)

C. Drugs which enhance glucose urinary excretion-SGLT-2inhibitors (gliflozins)
Sodium-Glucose Cotransporter 2inhibitor (Canagliflozin (Invokana)
Dapagliflozin (Farxiga)

D.incretins - DPP-4 inhibitors (gliptins)
Saxagliptin (Onglyza)
Linagliptin (Tradjenta)

24
Q

Subcutaneous form

A

Incretin- glp-1 analogues

GLP-1 receptor agonists are a class of injectable medications that mimic the actions of GLP-1, leading to improved glucose control in people with type 2 diabetes. Examples include:
Exenatide (Byetta, Bydureon)
Liraglutide (Victoza, Saxenda)
Dulaglutide (Trulicity)
Semaglutide (Ozempic)

Insulin

25
Q

SE of diabetes M drugs

A

Metformin:
Gastrointestinal (GI) side effects, such as nausea, diarrhea, and abdominal pain
Rarely, lactic acidosis

Sulfonylureas:
Hypoglycemia (low blood sugar,Weight gain
GI issues, like nausea and heartburn

Thiazolidinediones (TZDs):
Weight gain,Fluid retention and edema,Increased risk of bone fractures
Rarely, liver problems

DPP-4 Inhibitors:
Upper respiratory tract infectionsHeadaches, pancreatitis

SGLT-2 Inhibitors:
Genital and urinary tract infections
Increased urination, diabetic ketoacidosis (DKA)

GLP-1 Receptor Agonists:
Nausea,Vomiting,Diarrhea,Constipation,Reduced appetite
Rarely, pancreatitis or allergic reactions

Insulin:
Hypoglycemia (low blood sugar)
Weight gain
Local injection site reactions, like irritation or swelling

Bile Acid Sequestrants:
GI side effects, like constipation, bloating, and heartburn
Reduced absorption of certain vitamins and other drugs